OSCR

CD22 regulates Aβ clearance in microglia through INPP5D signaling.

Overview

Authors: De-Zhi Zou1, Jun Li2, Qiu-Shuang Long3, Ruo-Qi Zhang3, Bing-Lin Zhu3, Jia-Ze Tan1
  1. Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  2. Brain Research Center and State Key Laboratory of Trauma, Burns, and Combined Injury, The Army Medical University (Third Military Medical University), Chongqing, China
  3. Institute of Advanced Pathology Research, Jinfeng Laboratory, Chongqing, China
Journal: Frontiers in cellular neuroscience, volume 20, article 1886995
Dates: received 21 May 2026; accepted 15 July 2026; published online 28 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fncel.2026.1886995 · PMID 42582107 · PMCID PMC13457040 · OpenAlex W7171539992
Open access: gold, a free copy (OpenAlex)
Categories: mouse (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Alzheimer's disease, Aβ clearance, CD22, INPP5D, primary microglia
Topic: Neuroinflammation and Neurodegeneration Mechanisms (Neurology, Neuroscience), according to OpenAlex
Citations: not cited yet (Europe PMC); 24 references in the paper

Abstract

Introduction: Impaired microglial clearance of amyloid-β (Aβ) is a central driver of Alzheimer's disease (AD), yet the mechanisms governing intracellular Aβ degradation remain poorly defined.

Methods: We investigated the role of CD22 in microglial Aβ processing using primary microglia, transcriptomic profiling, and hippocampal samples from AD patients and transgenic mice.

Results: We identified CD22 as an Aβ-inducible signaling regulator that restrains microglial Aβ processing. CD22 expression was elevated in the hippocampus of AD patients and transgenic mice and was rapidly induced by Aβ in microglia. Functionally, CD22 knockdown enhanced intracellular Aβ degradation without affecting initial uptake. Transcriptomic profiling identified the AD risk gene INPP5D as a key downstream effector of CD22. Loss of CD22 suppressed INPP5D expression and promoted AKT activation, while INPP5D overexpression partially rescued the enhanced Aβ clearance phenotype. These findings define a CD22-INPP5D signaling axis that acts as a molecular brake on microglial Aβ processing. Aβ itself induces CD22 expression, revealing a feed-forward inhibitory loop in which amyloid accumulation limits its own clearance.

Discussion: Collectively, these findings identify a regulatory mechanism controlling intracellular Aβ degradation and suggest the CD22-INPP5D axis as a potential therapeutic target for AD.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 6 authors, 5 keywords, 2 funders, 24 references.

Cite

This paper

Zou, D.-Z., Li, J., Long, Q.-S., Zhang, R.-Q., Zhu, B.-L., & Tan, J.-Z. (2026). CD22 regulates Aβ clearance in microglia through INPP5D signaling. Frontiers in cellular neuroscience, 20, 1886995. https://doi.org/10.3389/fncel.2026.1886995

BibTeX

@article{zou2026cd22,
author = {Zou, De-Zhi and Li, Jun and Long, Qiu-Shuang and Zhang, Ruo-Qi and Zhu, Bing-Lin and Tan, Jia-Ze},
title = {{CD22 regulates Aβ clearance in microglia through INPP5D signaling}},
journal = {Frontiers in cellular neuroscience},
year = {2026},
month = jul,
volume = {20},
pages = {1886995},
publisher = {Frontiers Media SA},
issn = {1662-5102},
doi = {10.3389/fncel.2026.1886995},
url = {https://doi.org/10.3389/fncel.2026.1886995},
pmid = {42582107},
pmcid = {PMC13457040}
}

RIS

TY - JOUR
AU - Zou, De-Zhi
AU - Li, Jun
AU - Long, Qiu-Shuang
AU - Zhang, Ruo-Qi
AU - Zhu, Bing-Lin
AU - Tan, Jia-Ze
TI - CD22 regulates Aβ clearance in microglia through INPP5D signaling
T2 - Frontiers in cellular neuroscience
J2 - Front Cell Neurosci
PY - 2026
DA - 2026/07/28
VL - 20
SP - 1886995
SN - 1662-5102
PB - Frontiers Media SA
DO - 10.3389/fncel.2026.1886995
UR - https://doi.org/10.3389/fncel.2026.1886995
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fncel.2026.1886995",
"type": "article-journal",
"title": "CD22 regulates Aβ clearance in microglia through INPP5D signaling",
"container-title": "Frontiers in cellular neuroscience",
"author": [
{
"family": "Zou",
"given": "De-Zhi"
},
{
"family": "Li",
"given": "Jun"
},
{
"family": "Long",
"given": "Qiu-Shuang"
},
{
"family": "Zhang",
"given": "Ruo-Qi"
},
{
"family": "Zhu",
"given": "Bing-Lin"
},
{
"family": "Tan",
"given": "Jia-Ze"
}
],
"container-title-short": "Front Cell Neurosci",
"volume": "20",
"page": "1886995",
"DOI": "10.3389/fncel.2026.1886995",
"PMID": "42582107",
"PMCID": "PMC13457040",
"ISSN": "1662-5102",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fncel.2026.1886995",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
28
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1007/s00018-023-04775-y
Aging microglia.
Journal: Cellular and molecular life sciences : CMLS
In common: cellular / molecular, 4 references
[2] doi:10.1186/s41232-025-00383-4
Unraveling the complex role of microglia in Alzheimer's disease: amyloid β metabolism and plaque formation.
Journal: Inflammation and regeneration
In common: Alzheimer's / dementia, cellular / molecular, 4 references
[3] doi:10.1186/s12974-023-02870-2
Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer's disease.
Journal: Journal of neuroinflammation
In common: Alzheimer's / dementia, mouse, cellular / molecular, 3 references
[4] doi:10.1073/pnas.2303760120 [code]
CARD9 attenuates Aβ pathology and modifies microglial responses in an Alzheimer's disease mouse model.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: Alzheimer's / dementia, mouse, cellular / molecular, 3 references
[5] doi:10.1186/s13024-024-00793-x
APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.
Journal: Molecular neurodegeneration
In common: Alzheimer's / dementia, mouse, cellular / molecular, 3 references
[6] doi:10.1084/jem.20260104 [code]
Alzheimer's genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis.
Journal: The Journal of experimental medicine
In common: Alzheimer's / dementia, mouse, 3 references
[7] doi:10.1186/s13024-023-00674-9
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease.
Journal: Molecular neurodegeneration
In common: Alzheimer's / dementia, cellular / molecular, 3 references
[8] doi:10.1111/cns.13899
Phagocytic microglia and macrophages in brain injury and repair.
Journal: CNS neuroscience & therapeutics
In common: cellular / molecular, 3 references
[9] doi:10.1002/alz.71471 [code]
How does type 2 diabetes modify the risk of Alzheimer's disease?
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: Alzheimer's / dementia, cellular / molecular, 3 references
[10] doi:10.1186/s40478-025-02143-4 [code]
Gene module-trait network analysis uncovers cell type specific systems and genes relevant to Alzheimer's Disease.
Journal: Acta neuropathologica communications
In common: Alzheimer's / dementia, cellular / molecular, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.